These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7201820)

  • 1. [Drug safety and therapeutic index / Principles of pharmacological screening and of the clinical transferability of animal experiments results (author's transl)].
    Schneider B
    Arzneimittelforschung; 1982; 32(5):471-4. PubMed ID: 7201820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles of controlled trials (author's transl)].
    Fink H
    Arzneimittelforschung; 1978; 28(11a):2017-9. PubMed ID: 383091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of experimental results in clinical tumor chemotherapy (author's transl)].
    Somfai-Relle S; Sugár J
    Arch Geschwulstforsch; 1980; 50(2):132-40. PubMed ID: 7436697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of results of animal experiments for the evaluation of drugs. 3. Animal trials and subjective probability].
    Burkhardt R; Kienle G; Knipping W
    Fortschr Med; 1976 Apr; 94(12):719-24. PubMed ID: 964836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical predictors of clinical safety: opportunities for improvement.
    Sistare FD; DeGeorge JJ
    Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Workshop on the Use of Pharmacological Methods in Safety-Evaluation of New Drugs, 1977. Proceedings.
    Pharmacol Ther B; 1979; 5(1-3):1-605. PubMed ID: 493303
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical formulations for discovery and toxicology: physicochemical challenges.
    Neervannan S
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):715-31. PubMed ID: 17014391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop.
    Ludolph AC; Bendotti C; Blaugrund E; Hengerer B; Löffler JP; Martin J; Meininger V; Meyer T; Moussaoui S; Robberecht W; Scott S; Silani V; Van Den Berg LH;
    Amyotroph Lateral Scler; 2007 Aug; 8(4):217-23. PubMed ID: 17653919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.
    Newell DR; Burtles SS; Fox BW; Jodrell DI; Connors TA
    Br J Cancer; 1999 Nov; 81(5):760-8. PubMed ID: 10555743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 15 antineoplastic drugs on colon carcinoma growing in vitro: a screening assay for cytotoxicity (author's transl)].
    Gouget N; Jeannin JF; Olsson O; Martin F
    Bull Cancer; 1980; 67(2):155-60. PubMed ID: 7448437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of the results of animal experiments for the evaluation of drugs. 2. Methodology and prediction of effects].
    Burkhardt R; Kienle G; Knipping W
    Fortschr Med; 1976 Mar; 94(9):482-6. PubMed ID: 964908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating the "size of mesh" in drug screening from statistical point of view demonstrated by a 2-step procedure of in vivo testing of antiviral compounds.
    Horn M; Veckenstedt A; Kanka U
    Arzneimittelforschung; 1977; 27(11):2032-5. PubMed ID: 579996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.